Skip to main content
Premium Trial:

Request an Annual Quote

Women and Infants Hospital to Study Use of Natera Prenatal Screen

NEW YORK (GenomeWeb News) – The Women and Infants Hospital of Rhode Island will be using funding from genetic testing firm Natera to study the use of the company's prenatal blood test for Down syndrome and other chromosomal abnormalities in a general clinical setting.

Investigators at the hospital plan to focus their efforts on finding out how much information and education women in the general pregnancy population need about the test, called Panorama, which has been used so far been used to screen women in high-risk groups, the hospital said today.

"This is not a study of the test itself. We already know that DNA-based screening is highly effective. Rather, we need to look at its implementation in the general population to determine how best to educate professionals and patients," Women and Infants' Glenn Palomaki said in a statement.

The investigators also plan to contact a group of around 100 women who have had the DNAFirst screening – out of a total of around 3,500 who will have the test in Rhode Island - and who match a specific set of clinical and demographic characteristics, to ask them about their experiences having the test through a 15-minute survey.

Palomaki has already been conducting studies aimed at understanding how to integrate genomic medicine in maternal clinical care.

In 2011, he published an external validation study of the use of next-generation sequencing of circulating cell-free DNA in maternal plasma to identify common chromosome abnormalities, Women and Infants said.

Filed under

The Scan

Guidelines for Ancient DNA Work

More than two dozen researchers have developed new ethical guidelines for conducting ancient DNA research, which they present in Nature.

And Cleared

A UK regulator has cleared former UK Prime Minister David Cameron in concerns he should have registered as a consultant-lobbyist for his work with Illumina, according to the Financial Times.

Suit Over Allegations

The Boston Globe reports that David Sabatini, who was placed on leave from MIT after allegations of sexual harassment, is suing his accuser, the Whitehead Institute, and the institute's director.

Nature Papers on Esophageal Cancer, Origin of Modern Horses, Exome Sequencing of UK Biobank Participants

In Nature this week: genetic and environmental influences of esophageal cancer, domestic horse origin traced to Western Eurasian steppes, and more.